128 related articles for article (PubMed ID: 2112726)
1. Treatment of mitomycin-C-associated hemolytic uremic syndrome with plasmapheresis.
Poch E; Almirall J; Nicolas JM; Torras A; Revert L
Nephron; 1990; 55(1):89-90. PubMed ID: 2112726
[No Abstract] [Full Text] [Related]
2. Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis.
Garibotto G; Acquarone N; Saffioti S; Deferrari G; Villaggio B; Ferrario F
Nephron; 1989; 51(3):409-12. PubMed ID: 2493141
[TBL] [Abstract][Full Text] [Related]
3. Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
Murgo AJ
Am J Kidney Dis; 1987 Mar; 9(3):241. PubMed ID: 3826074
[No Abstract] [Full Text] [Related]
4. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
Cantrell JE; Phillips TM; Schein PS
J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
[TBL] [Abstract][Full Text] [Related]
5. Hemolytic-uremic syndrome after cancer chemotherapy without mitomycin C.
Desablens B; Fievet P; Pruna A; Claisse JF; Westeel PF; Tolani M; Fournier A
Nephron; 1986; 42(4):343-4. PubMed ID: 3083278
[No Abstract] [Full Text] [Related]
6. Mitomycin-induced hemolytic-uremic syndrome. Successful treatment with corticosteroids and intense plasma exchange.
Lyman NW; Michaelson R; Viscuso RL; Winn R; Mulgaonakar S; Jacobs MG
Arch Intern Med; 1983 Aug; 143(8):1617-8. PubMed ID: 6870446
[TBL] [Abstract][Full Text] [Related]
7. Recovery from mitomycin C-induced hemolytic uremic syndrome. A case report.
Verwey J; Boven E; van der Meulen J; Pinedo HM
Cancer; 1984 Dec; 54(12):2878-81. PubMed ID: 6437662
[TBL] [Abstract][Full Text] [Related]
8. [Hemolytic-uremic syndrome caused by mitomycin C].
de Insausti CL; Gutiérrez LE
Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
[No Abstract] [Full Text] [Related]
9. [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology].
Cordonnier D; Vert-Pré FC; Bayle F; Alix JL; Couderc P
Nephrologie; 1985; 6(1):19-26. PubMed ID: 3923381
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary angiomatoid vascular changes in mitomycin C-associated hemolytic-uremic syndrome.
Chang-Poon VY; Hwang WS; Wong A; Berry J; Klassen J; Poon MC
Arch Pathol Lab Med; 1985 Sep; 109(9):877-8. PubMed ID: 3927871
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of the hemolytic-uremic syndrome in adults].
Grabensee B; Passlick J
Dtsch Med Wochenschr; 1987 Jul; 112(27):1089-91. PubMed ID: 3595471
[No Abstract] [Full Text] [Related]
12. Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
Chow S; Roscoe J; Cattran DC
Am J Kidney Dis; 1986 May; 7(5):407-12. PubMed ID: 3085480
[TBL] [Abstract][Full Text] [Related]
13. Haemolytic-uraemic syndrome associated with mitomycin-C treatment.
Wils J; Grave W; van Breda Vriesman PJ
Neth J Med; 1987 Feb; 30(1-2):32-5. PubMed ID: 3108684
[No Abstract] [Full Text] [Related]
14. [Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature].
Nicolás JM; Villalta J; González-Clemente JM; Antúnez E; Almirall J; Bosch J; Torras A; Urbano-Márquez A
Rev Clin Esp; 1990 Mar; 186(4):166-70. PubMed ID: 2114657
[TBL] [Abstract][Full Text] [Related]
15. Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
Willie GR; Levy SM; Michaels RS; Zirkin RM
Henry Ford Hosp Med J; 1983; 31(2):104-9. PubMed ID: 6313552
[No Abstract] [Full Text] [Related]
16. Two patients with a fatal haemolytic-uremic syndrome after combination therapy including mitomycin C.
Boven E; Pinedo HM
Neth J Med; 1983; 26(9):288. PubMed ID: 6419135
[No Abstract] [Full Text] [Related]
17. Hemolytic-uremic syndrome associated with mitomycin therapy.
Pavy MD; Wiley EL; Abeloff MD
Cancer Treat Rep; 1982 Mar; 66(3):457-61. PubMed ID: 7060035
[No Abstract] [Full Text] [Related]
18. Two patients suffering from interstitial pneumonitis and haemolytic-uraemic syndrome as side effects of mitomycin C therapy.
van Spreeuwel JP; Hemrika MH; de Maat CE; Nadorp JH
Neth J Med; 1983; 26(9):287-8. PubMed ID: 6419134
[No Abstract] [Full Text] [Related]
19. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated hemolytic uremic syndrome: a possible role of mitomycin in relation to Shiga-like toxins.
Acheson DW; Donohue-Rolfe A
J Clin Oncol; 1989 Dec; 7(12):1943. PubMed ID: 2511278
[No Abstract] [Full Text] [Related]
[Next] [New Search]